Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Rugeles, Jorge Andres"'
Autor:
Rugeles, Jorge Andres, Cotes, Martha
Publikováno v:
Parkin DM, Bray F, Ferlay J, et al. Global cancer sta-tistics, 2002. CA Cancer J Clin 2005;55(2):74–108.
Vigneswaran N, Williams MD. Epidemiologic Trends in Head and Neck Cancer and Aids in Diagnosis. Oral Maxillofac Surg Clin North Am. 2014 May;26(2):123-41. doi: 10.1016/j.coms.2014.01.001.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45(4–5):309–16
Pardo C, Cendales R. Incidencia estimada y mortalidad por cáncer en Colombia 2002-2006. Bogotá; Instituto Nacional de Cancerología; 2010
Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110(7):1429–35
Argiris A, Karamouzis MV, et al. Head and neck cancer. Lancet 2008 May 17;371(9625):1695-709. doi: 10.1016/S0140-6736(08)60728-X.
Tribius S, Bergelt C. Intensity-modulated radiotherapy versus con-ventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev. 2011;37:511-519.
Nutting CM, Morden JP, Harrington KJ, et al; PARSPORT trial management group. Parotid-sparing intensity modulated versus con-ventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011; 12:127-136.
Lee IJ, Koom WS, Lee CG, et al. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyn-geal cancer patients. Int J Radiat Oncol Biol Phys. 2009;75:1084-1091.
Cooper JS, Farnan NC, Asbell SO, Rotman M, Marcial V, Fu KK, McKenna WG, Emami B. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer. 77 (1996)(9):1905-11.
Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol. 2003;42(5-6):443-61.
Lin D, Cohen S, et al. Squamous cell carcinoma of the oropharynx and hypopharynx. Otolaryngology Clinics of North America 38 (2005) 59–74.
Pignon J.P., Bourhis J, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data . Lancet 355 (2000) 949–55.
Yao M, Epstein J.B., et al. Current surgical treatment of squamouscell carcinoma of the head and neck . Oral Oncology 43(2007) 213– 223.
Vigneswaran N, Williams MD. Epidemiologic Trends in Head and Neck Cancer and Aids in Diagnosis. Oral Maxillofac Surg Clin North Am. 2014 May;26(2):123-41. doi: 10.1016/j.coms.2014.01.001.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45(4–5):309–16
Pardo C, Cendales R. Incidencia estimada y mortalidad por cáncer en Colombia 2002-2006. Bogotá; Instituto Nacional de Cancerología; 2010
Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110(7):1429–35
Argiris A, Karamouzis MV, et al. Head and neck cancer. Lancet 2008 May 17;371(9625):1695-709. doi: 10.1016/S0140-6736(08)60728-X.
Tribius S, Bergelt C. Intensity-modulated radiotherapy versus con-ventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev. 2011;37:511-519.
Nutting CM, Morden JP, Harrington KJ, et al; PARSPORT trial management group. Parotid-sparing intensity modulated versus con-ventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011; 12:127-136.
Lee IJ, Koom WS, Lee CG, et al. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyn-geal cancer patients. Int J Radiat Oncol Biol Phys. 2009;75:1084-1091.
Cooper JS, Farnan NC, Asbell SO, Rotman M, Marcial V, Fu KK, McKenna WG, Emami B. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer. 77 (1996)(9):1905-11.
Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol. 2003;42(5-6):443-61.
Lin D, Cohen S, et al. Squamous cell carcinoma of the oropharynx and hypopharynx. Otolaryngology Clinics of North America 38 (2005) 59–74.
Pignon J.P., Bourhis J, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data . Lancet 355 (2000) 949–55.
Yao M, Epstein J.B., et al. Current surgical treatment of squamouscell carcinoma of the head and neck . Oral Oncology 43(2007) 213– 223.
Objetivo: Describir las características sociodemográficas, clínicas, complicaciones, supervivencia global y libre de enfermedad y adherencia al tratamiento en pacientes con cáncer escamocelular de cabeza y cuello, tratados con radioterapia extern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2802::75caf2264fd88c273aa1902b73af209b
https://hdl.handle.net/10654/6663
https://hdl.handle.net/10654/6663
